Company / Free Cash Flow
BioLife Solutions, Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$10.6M
FY2025
5-year range
-$18.9M / $10.6M
FY2021-FY2025
Trend
+104.4%
vs FY2024
Sector context
#109 of 145
Health Care
What the data says
BioLife Solutions, Inc.'s free cash flow of $11M is lower than 75% of companies in the Health Care sector (FY2025). Free Cash Flow has fluctuated over the past 10 years, ranging from -$19M in FY2023 to $11M in FY2025.
Based on SEC 10-K filings.
$11M in FY2025 with a 5-year CAGR of +17.8%.
Improved from -$19M to $11M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +17.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 145This company $10.6M Sector average $770.9M
▼
-98.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.8%, indicating consistent growth.
- In FY2025, free cash flow increased 104.4% year-over-year.
- Ranks #109 out of 145 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.6M | +104.4% |
| FY2024 | $5.2M | +127.6% |
| FY2023 | -$18.9M | -0.0% |
| FY2022 | -$18.9M | -45.4% |
| FY2021 | -$13.0M | -377.1% |
| FY2020 | $4.7M | +770.6% |
| FY2019 | $538.0K | +53.3% |
| FY2018 | $351.0K | -23.9% |
| FY2017 | $461.0K | +110.3% |
| FY2016 | -$4.5M | +12.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026